Sign up for the QMED & MD+DI Daily newsletter.
Diagnostics Company Developing Micro-Lab Device Seeking $7 million
Medical venture capital may be hard to come by, but that isn't stopping novel diagnostics firm Ativa Medical, which is issuing debt to raise $7 million.
June 5, 2013
1 Min Read
Medical venture capital may be tough to come by but Ativa Medical, a novel diagnostics company in Minnesota, appears to have chosen the debt route to raise money.
A regulatory filing with the Securities & Exchange Commission shows that Ativa Medical is looking to issue debt in the amount of $7 million. A previous filing from July 2012 shows that the company raised $3.4 million in its quest to raise a total of $10 million. That was however, an equity financing round.
Incorporated in 2008, the company is developing what it claims is the "world's first micro-lab," an affordable device that uses a single drop of blood. The blood is placed on a test card and inserted in an analyzer that can within 3 to 5 minutes display results and transfer the data to other information systems.
In other words, physicians no longer need to wait for a central lab to process the tests, which in turn lengthens the time to make a diagnosis.
-- By Arundhati Parmar, Senior Editor, MD+DI
You May Also Like
Pedersen's POV graphic featuring the headshot of MD+DI Senior Editor Amanda Pedersen and a pull quote from the latest edition of her opinion column.
BioSig's Ridiculously Sparse Layoff Announcement Reeks of CallousnessFeb 26, 2024|3 Min Read
Sourcing Electrical Components: Are We Back to Normal?Feb 26, 2024|6 Min Read
Your Smartwatch Can’t Measure Blood Glucose Levels… YetFeb 26, 2024|3 Min Read
Medtech in a Minute: Medtronic Pulls the Plug on Ventilators and MoreFeb 26, 2024|1 Min Read